Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model

Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model

Abstract Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver cirrhosis. Wnt/β-catenin signaling has been implicated in the pathogenesis of a variety of tissue fibrosis....

Full description

Bibliographic Details
Main Authors:	Yuko Tokunaga, Yosuke Osawa, Takahiro Ohtsuki, Yukiko Hayashi, Kenzaburo Yamaji, Daisuke Yamane, Mitsuko Hara, Keisuke Munekata, Kyoko Tsukiyama-Kohara, Tsunekazu Hishima, Soichi Kojima, Kiminori Kimura, Michinori Kohara
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-00282-w

Similar Items

Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder
by: Kenzaburo Yamaji, et al.
Published: (2023-10-01)

Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
by: Yosuke Osawa, et al.
Published: (2015-11-01)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
by: Masamichi Kimura, et al.
Published: (2022-10-01)

Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver.
by: Satoshi Sekiguchi, et al.
Published: (2012-01-01)

Basic Study for Vaccine Development Targeting Virus Infections
by: Kyoko Tsukiyama-Kohara, et al.
Published: (2021-12-01)

Longer Poly(U) Stretches in the 3′UTR Are Essential for Replication of the Hepatitis C Virus Genotype 4a Clone in in vitro and in vivo
by: Asako Takagi, et al.
Published: (2021-11-01)

TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2023-12-01)

Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2023-06-01)

Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-05-01)

Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-09-01)

Epidemiology and Risk Factors for Acute Viral Hepatitis in Bangladesh: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-11-01)

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-11-01)

Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies
by: Tomoko Honda, et al.
Published: (2021-06-01)

Increasing Dengue Burden and Severe Dengue Risk in Bangladesh: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2023-01-01)

Tree Shrew as an Emerging Small Animal Model for Human Viral Infection: A Recent Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-08-01)

Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development
by: Sayeh Ezzikouri, et al.
Published: (2020-12-01)

3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
by: Makoto Saito, et al.
Published: (2015-01-01)

Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B
by: Sayeh Ezzikouri, et al.
Published: (2020-05-01)

Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-09-01)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
by: Kiminori Kimura, et al.
Published: (2017-09-01)

Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus
by: Bouchra Kitab, et al.
Published: (2023-01-01)

In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-07-01)

Response to the Letter to the Editor Regarding “Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021”
by: Takahiro Sanada, et al.
Published: (2023-02-01)

Application of spatial transcriptomics analysis using the Visium system for the mouse nasal cavity after intranasal vaccination
by: Sakiko Toyama, et al.
Published: (2023-07-01)

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
by: Philipp Manegold, et al.
Published: (2018-03-01)

Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
by: Eva Gravesen, et al.
Published: (2018-01-01)

Toll-Like Receptor Expression Profiles in Koala (<i>Phascolarctos cinereus</i>) Peripheral Blood Mononuclear Cells Infected with Multiple KoRV Subtypes
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-04-01)

Toll-Like Receptor and Cytokine Responses to Infection with Endogenous and Exogenous Koala Retrovirus, and Vaccination as a Control Strategy
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-04-01)

CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2
by: Dingqing Feng, et al.
Published: (2021-01-01)

A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
by: Mya Myat Ngwe Tun, et al.
Published: (2023-12-01)

Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the CBP/β-catenin inhibitor PRI-724 in patients with liver cirrhosis
by: Mayu Yoshida, et al.
Published: (2024-03-01)

Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models
by: Makoto Saito, et al.
Published: (2021-05-01)

Suppression of dengue virus replication by the French maritime pine extract Pycnogenol®
by: Kazi Anowar Hossain, et al.
Published: (2024-01-01)

Exosome RNA Released by Hepatocytes Regulates Innate Immune Responses to Hepatitis B Virus Infection
by: Takahisa Kouwaki, et al.
Published: (2016-08-01)

Isolation and characterization of highly replicable hepatitis C virus genotype 1a strain HCV-RMT.
by: Masaaki Arai, et al.
Published: (2013-01-01)

Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells
by: Mingtian Che, et al.
Published: (2020-06-01)

Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-08-01)

Development of short hairpin RNA expression vectors targeting the internal ribosomal entry site of the classical swine fever virus genomic RNA
by: Riai Okamoto, et al.
Published: (2023-09-01)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
by: Alexander Ring, et al.
Published: (2018-12-01)

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
by: Vinay K. Kartha, et al.
Published: (2018-07-01)